Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Heart Failure Devices Must Be “Smarter,” Reverse Disease – HFSA President

This article was originally published in The Gray Sheet

Executive Summary

Heart failure devices should reverse the underlying biochemical causes of disease instead of merely supporting or replacing a dysfunctional part, according to Heart Failure Society of America President Marvin Konstam, MD, New England Heart Center

You may also be interested in...



CRT-P Versus CRT-D: A Match-Up Likely Never To Be Seen – NEJM Editoral

Cardiac resynchronization with cardioverter defibrillation devices (CRT-D) will continue to be used more often than CRT-alone, even though the latter option may actually be better for some heart failure patients, according to John Jarcho, MD, Brigham & Women's Hospital, Boston

CRT-P Versus CRT-D: A Match-Up Likely Never To Be Seen – NEJM Editoral

Cardiac resynchronization with cardioverter defibrillation devices (CRT-D) will continue to be used more often than CRT-alone, even though the latter option may actually be better for some heart failure patients, according to John Jarcho, MD, Brigham & Women's Hospital, Boston

Acorn Releases CorCap Pivotal Trial Results, Anticipates 2005 Panel Review

Acorn Cardiovascular is planning a 2005 continued access protocol for its CorCap cardiac support device, which the company would like to see incorporated into an FDA-mandated post-market study

Related Content

UsernamePublicRestriction

Register

MT021037

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel